The Asia Pacific region presents one of the most compelling growth opportunities for technology companies today. Its dynamic markets, rapid digitalization, and increasing demand for advanced solutions are impossible to ignore. However, many suppliers find that their initial market entry strategy is more complex than anticipated. Often, the challenge lies in underestimating what is required…
Gene therapy involves introducing new genetic material into cells so that abnormal genes causing bad protein-coding functions are altered, replaced or silenced. It is most active in the treatment of cancer, accounting for over 60 percent of clinical trials and over 50 percent of all approved therapies worldwide.
South East Asia, with an overall aging population, growing intra-Asian trade and increased emphasis on education is perfectly positioned for growth in the scientific and analytical instrumentation industry.
Delivering Growth – in Asia and Beyond.
© DKSH International Ltd.
Please enter your details here:
